Hepatobiliary cytoprotective pathways

Hepatobiliary cytoprotective pathways refer to the integrated cellular and molecular mechanisms that safeguard hepatocytes and cholangiocytes from damage, primarily caused by the accumulation of toxic bile acids during cholestasis (Beuers et al., 2010, Hepatology). These pathways are regulated by a suite of nuclear receptors, including the Farnesoid X Receptor (FXR), Pregnane X Receptor (PXR), and Peroxisome Proliferator-Activated Receptors (PPARs), which coordinate the synthesis, detoxification, and transport of bile acids (Trauner et al., 2017, Journal of Hepatology). A critical component is the "bicarbonate umbrella," which maintains a protective alkaline environment on the apical surface of cholangiocytes to prevent the entry of protonated, toxic bile acids (Hohenester et al., 2012, Seminars in Liver Disease). In diseases such as Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC), these pathways are often compromised, leading to progressive liver injury and fibrosis. Pharmacological intervention, such as the use of Ursodeoxycholic acid (UDCA) or FXR agonists like Obeticholic acid, aims to reinforce these cytoprotective mechanisms to slow disease progression and improve liver function (Poupon, 2010, Journal of Hepatology).

Other names

Hepatoprotective pathwaysBiliary cytoprotective mechanismsBile acid detoxification pathwaysBiliary bicarbonate umbrella

Activation of nuclear receptors (e.g., FXR, PXR, PPAR) to regulate bile acid synthesis and transport, stimulation of biliary bicarbonate secretion (the biliary umbrella), and induction of antioxidant and anti-apoptotic signaling.